Global Cannabis Stocks Close Out Challenging Year with 1.1% Gain in December

After beginning the year with a 57.4% gain in Q1 and then dropping for eight consecutive months, the Global Cannabis Stock Index ended December with a big jump that enabled the index to gain 1.1% for the month, closing at 42.20:

The index, which had 44 qualifying members during the month following the quarterly rebalancing at the end of September, declined 54.9% in 2018 and lost 34.1% in 2019:

The decline left the index at levels not seen in over three years, down almost 77% from its early 2018 closing high at 180.02 but up 9.3% from its closing low on December 18th at 38.62:

5 names gained more than 20% during December:

Origin House’s strength was driven by the rally in Cresco Labs, with which it is merging in January in an all-stock deal, compounded by a narrowing of the discount to the price implied by the transaction based upon the price of Cresco Labs from 16% to just over 5%.  Sundial, which conducted its IPO at $13 during the summer, bounced off of a post-IPO low set in early December at $1.88. Cresco Labs rallied ahead of legalization in Illinois and its pending acquisition of Origin House. The company also raised $50 million in an additional sale/leaseback transaction announced during the month. Harvest Health & Recreation surged in the final days of the month after it priced a large debt offering. Planet 13 was a top performer for the second consecutive month.

5 names fell by more than 20% during December:

Elixinol’s weakness was due to competitive pressures in the industry as well as the resignation of its founder, Paul Benhaim, who had recently moved into the role of Chief Innovation Officer after having served as CEO. HEXO crushed its stock with a capital raise the day after Christmas that was significantly below the prior closing price. Emerald Health also suffered from a capital raise that pressured its stock along with ongoing concerns regarding its cannabis joint venture, Pure Sunfarms. Charlotte’s Web and CV Sciences, like Elixinol, continued to see pressure on their stocks after a slowdown in growth for the companies and the overall CBD sector became apparent in November during the financial reporting season.

We have also published separate reviews of the performance of the Canadian LP Index and the American Cannabis Operators Index:

Using data from 12/20, we have rebalanced the index, effective as of 12/31. As a result of lower trading volumes, we have slightly reduced the minimum average daily value traded from $800K to $500K, our first change in more than a year. The number of names in the index in January will be 41, as we have removed nine names and added six new ones. Departing the index due to no longer meeting price or volume criteria are Canopy Rivers (TSX:  RIV) (OTC: CNPOF), Elixnol Global (ASX: EXL) (OTC: ELLXF), Emerald Health (TSXV: EMH) (OTC: EMHTF), Fire & Flower (TSX: FAF) (OTC: FFLWF), Flowr (TSXV: FLWR) (OTC: FLWPF), Khiron (TSXV: KHRN) (OTC: KHRNF), Namaste Technologies (TSXV: N) (OTC: NXTTF) and PharmaCielo (TSXV: PLCO) (OTC: PCLOF). We have also removed Origin House (CSE: OH) (OTC: ORHOF) ahead of its pending acquisition by Cresco Labs (CSE: CL) (OTC: CRLBF).

Joining the index are Akerna (NASDAQ: KERN), Green Growth Brands (CSE: GGB) (OTC: GGBXF), GrowGeneration (NASDAQ: GRWG), Liberty Health Sciences (CSE: LHS) (OTC: LHSIF), TerrAscend (CSE: TER) (OTC: TRSSF) and Vireo Health (CSE: VREO) (OTC: VREOF).

We will summarize the index performance again in a month. You can learn more about the index members and the qualifications for inclusion by visiting the Global Cannabis Stock Index. A more complete analysis of the index is available at 420Investor.com. Be sure to bookmark the page to stay current on cannabis stock price movements within the day or from day-to-day.

New Cannabis Ventures maintains six proprietary indices designed to help investors monitor the publicly-traded cannabis stocks, including the Global Cannabis Stock Index as well as the Canadian Cannabis LP Index and its three sub-indices. The sixth index, the American Cannabis Operator Index, was launched at the end of October last year and tracks the leading cultivators, processors and retailers of cannabis in the United States.

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter